MedTrace Logo

Ocriplasmin Research to Better Inform Treatment (ORBIT)

NCT02079883 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 540

Last updated 2016-06-21

No results posted yet for this study

Summary

This is a multicenter, prospective, observational, Phase 4 study that will assess clinical outcomes and safety of JETREA® administered in a real-world setting for the treatment of symptomatic vitreomacular adhesion (VMA) by assessing anatomical and functional outcomes in 1500 patients recruited across approximately 120 USA retina sites.

Conditions

  • Symptomatic Vitreomacular Adhesion

Sponsors & Collaborators

  • ThromboGenics

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2016-05-31
Completion
2016-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02079883 on ClinicalTrials.gov